Fathom -16
Payments companies reported to CMS as associated with Fathom -16. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fathom -16, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fathom -16
These are the largest totals companies reported as associated with Fathom -16. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kamalani Hanamaikai | Phoenix, AZ | Vascular & Interventional Radiology | $134.07 |
| Suveer Tatineni | Aurora, IL | Vascular & Interventional Radiology | $132.26 |
| Charles Daly | Lynnwood, WA | Vascular & Interventional Radiology | $132.26 |
| John Borsa | Kansas City, MO | Vascular & Interventional Radiology | $132.26 |
| Nilesh Patel | Myrtle Beach, SC | Vascular & Interventional Radiology | $132.26 |
| Ari Isaacson | Chapel Hill, NC | Vascular & Interventional Radiology | $121.51 |
| Christopher Harms | Tucson, AZ | Vascular & Interventional Radiology | $110.88 |
| Michael Hughes | Fruita, CO | Family Medicine | $75.51 |
| Ahmed Agha | Phoenix, AZ | Family Medicine | $72.19 |
| Kenaz Bakdash | Indianapolis, IN | Diagnostic Radiology | $70.67 |
Prescribed Fathom -16?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.